Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
4.120
-0.150 (-3.51%)
Feb 21, 2025, 4:00 PM EST - Market closed
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $139.14 million as of February 21, 2025. Its market cap has decreased by -46.57% in one year.
Market Cap
139.14M
Enterprise Value
65.90M
1-Year Change
-46.57%
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $139.14M, a decrease of -71.50%. That is a compound annual growth rate of -29.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 139.14M | -49.39% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |